| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 3.702 | 40.198 | 0 | 57.318 | 46.663 | 77.008 | 58.711 | 67.444 | 37.689 |
| Total Income - EUR | - | 3.723 | 44.219 | 0 | 57.722 | 46.881 | 77.749 | 58.752 | 67.461 | 37.713 |
| Total Expenses - EUR | - | 7.784 | 51.175 | 0 | 55.182 | 55.360 | 71.237 | 34.749 | 33.716 | 28.711 |
| Gross Profit/Loss - EUR | - | -4.061 | -6.956 | 0 | 2.540 | -8.479 | 6.511 | 24.003 | 33.745 | 9.002 |
| Net Profit/Loss - EUR | - | -4.139 | -7.283 | 0 | 2.032 | -8.885 | 5.728 | 23.441 | 33.166 | 8.681 |
| Employees | - | 1 | 1 | 0 | 1 | 1 | 2 | 1 | 1 | 1 |
Check the financial reports for the company - Paumy Med Vet Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 26.889 | 13.235 | 10.463 | 7.966 | 5.421 | 3.092 |
| Current Assets | - | 2.617 | 8.071 | 0 | 7.603 | 7.329 | 11.104 | 18.343 | 53.739 | 60.200 |
| Inventories | - | 1.510 | 7.701 | 0 | 1.820 | 3.639 | 734 | 9.689 | 8.963 | 8.913 |
| Receivables | - | 0 | 244 | 0 | 2.959 | 2.215 | 8.615 | 4.681 | 5.830 | 43.244 |
| Cash | - | 1.106 | 126 | 0 | 2.824 | 1.474 | 1.755 | 3.973 | 38.946 | 8.043 |
| Shareholders Funds | - | -4.139 | -11.124 | 0 | -8.562 | -17.252 | -11.141 | 12.265 | 45.394 | 53.811 |
| Social Capital | - | 0 | 0 | 0 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 6.756 | 19.195 | 0 | 43.054 | 37.815 | 32.708 | 14.044 | 13.766 | 9.480 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7500 - 7500" | |||||||||
| CAEN Financial Year |
7500
|
|||||||||
Comments - Paumy Med Vet Srl